Lombard Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue	12.17	15.11	13.28	6.96	6.18
Revenue Growth (YoY)	-19.48%	13.84%	90.76%	12.71%	-3.89%
Cost of Revenue	11.03	8.3	7.54	4.32	3.95
Gross Profit	1.14	6.82	5.74	2.65	2.22
Selling, General & Admin	18.99	34.63	31.16	15.72	8.01
Research & Development	7.67	11.28	9.21	6.96	7.3
Operating Expenses	26.66	45.91	40.38	22.68	15.31
Operating Income	-25.52	-39.09	-34.64	-20.03	-13.09
Interest Expense	-2.35	-1.19	-0.08	-0.45	-0.67
Interest & Investment Income	0.09	0.13	0.25	0.16	0.04
Currency Exchange Gain (Loss)	0.04	-	-	-	-
Other Non Operating Income (Expenses)	1.41	0.33	-	-	-
EBT Excluding Unusual Items	-26.33	-39.82	-34.48	-20.32	-13.72
Merger & Restructuring Charges	-	-0.2	-	-	-
Impairment of Goodwill	-0.86	-	-	-	-
Asset Writedown	-2.5	-	-	-	-
Other Unusual Items	-2.83	-	-1.5	-	-
Pretax Income	-32.52	-40.02	-35.98	-20.32	-13.72
Income Tax Expense	-1.48	-2.22	-1.23	-1.12	-0.56
Earnings From Continuing Operations	-31.04	-37.8	-34.75	-19.2	-13.16
Net Income	-31.04	-37.8	-34.75	-19.2	-13.16
Net Income to Common	-31.04	-37.8	-34.75	-19.2	-13.16
Shares Outstanding (Basic)	20	18	15	9	5
Shares Outstanding (Diluted)	20	18	15	9	5
Shares Change (YoY)	13.60%	21.99%	62.24%	77.98%	23.55%
EPS (Basic)	-1.54	-2.13	-2.39	-2.14	-2.61
EPS (Diluted)	-1.54	-2.13	-2.39	-2.14	-2.61
Free Cash Flow	-25.46	-35.04	-35.85	-19.6	-12.13
Free Cash Flow Per Share	-1.26	-1.97	-2.46	-2.18	-2.41
Gross Margin	9.38%	45.11%	43.20%	38.00%	36.00%
Operating Margin	-209.72%	-258.65%	-260.90%	-287.84%	-211.92%
Profit Margin	-255.03%	-250.13%	-261.75%	-275.92%	-213.15%
Free Cash Flow Margin	-209.22%	-231.81%	-270.05%	-281.59%	-196.42%
EBITDA	-24.22	-37.66	-33.47	-19.49	-12.78
EBITDA Margin	-199.03%	-249.17%	-252.08%	-280.00%	-206.90%
D&A For EBITDA	1.3	1.43	1.17	0.55	0.31
EBIT	-25.52	-39.09	-34.64	-20.03	-13.09
EBIT Margin	-209.72%	-258.65%	-260.90%	-287.84%	-211.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.